Abstract
Objective
The aim of our study was to investigate the effect of Pin1 on the telomerase activity in human colorectal carcinoma HCT116 cells.
Methods
Firstly, we transfected plasmid pGenesil-1-Pin1 (p-shRNA) using liposome (Lipofectamine 2000) into colorectal cancer HCT-116 cells to down-regulate the expression of Pin1. To detect the apoptotic rate of HCT116 cells was by cytometry (FCM). The expression of Pin1 and hTERT at RNA levels in human colorectal cancer HCT116 cells were determined by RT-PCR. To evaluate the activity of telomerase was by TRAP-silver staining. The subcellular localization and accumulative level of p-NF-κB/p65 protein at the nuclear was detected by Immunofluorescence and Western blotting. The DNA-binding activity of NF-κB/p65 was detected by electrophoretic mobility shift assay (EMSA).
Results
Using liposome into colorectal cancer HCT-116 cells, and down-regulate the expression of Pin1 (0.392 ± 0.072-fold; P = 0.001), and the apoptotic rate was increased (11.40% ± 1.54%; P < 0.05). Compared with transfected p-CON cell group, in transfected p-shRNA cell group, the transcription of hTERT was lower (0.171 ± 0.060-fold; P = 0.001) by quantitative real-time RT-PCR, and the results of TRAP-silver staining analysis suggested that the telomerase activity was significantly declined (0.384 ± 0.015-fold; P < 0.05). Furthermore, it was demonstrated by Immunofluorescence that p-NF-κB/p65 had a nuclear localization, and the level of p-NF-κB/p65 protein at the nuclear was reduced with silencing the expression of Pin1 by Western blotting. Using EMSA, it was suggested that NF-κB/p65 was able to bind to hTERT promoter, and the direct interaction was declined with silencing the expression of Pin1.
Conclusion
Taken together, silencing Pin1 may suppress activity of telomerase and the expression of hTERT by inhibiting NF-κB/p65 activity and reducing the combination of NF-κB/p65 and hTERT gene promoter.
This is a preview of subscription content, access via your institution.
References
Merika E, Saif MW, Katz A, et al. Review. Colon cancer vaccines: an update. In Vivo, 2010, 24: 607–628.
World Health Organization. Cancer. Fact sheet No297. January 2013.
Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet, 2010, 375: 1030–1047.
Ranganathan R, Lu KP, Hunter T, et al. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell, 1997, 89: 875–886.
Lu KP, Hanes SD, Hunter T, et al. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature, 1996, 380: 544–547.
Wulf G, Finn G, Suizu F, et al. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol, 2005, 7: 435–441.
Yeh ES, Means AR. Pin1, the cell cycle and cancer. Nat Rev Cancer, 2007, 7: 381–388.
Lee NY, Choi HK, Shim JH, et al. The prolylisomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis, 2009, 30: 671–681.
Xu GG, Etzkorn FA. Pin1 as an anticancer drug target. Drug News Perspect, 2009, 2: 399–407.
Saegusa M, Hashimura M, Kuwata T, et al. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells. J Pathol, 2010, 222: 410–420.
Ryo A, Suizu F, Yoshida Y, et al. Regulation of NF-kappaB signaling by Pin1-catalyzed prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell, 2003, 12: 1413–1426.
Kuramochi J, Arai T, Ikeda S, et al. High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol, 2006, 94: 155–160.
Kim CJ, Cho YG, Park YG, et al. Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World J Gastroenterol, 2005, 11: 5006–5009.
Bao L, Kimzey A, Sauter G, et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol, 2004, 164: 1727–1737.
Wulf GM, Ryo A, Wulf GG, et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J, 2001, 20: 3459–3472.
Rajendran P, Delage B, Dashwood WM, et al. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol Cancer, 2011, 10: 68.
Jin H, Jiang J, Sun L, Zheng F, et al. The prolyl isomerase Pin1 is overexpressed in human esophageal cancer. Oncol Lett, 2011, 2: 1191–1196.
Osterhage JL, Friedman KL. Chromosome end maintenance by telomerase. J Biol Chem, 2009, 284, 16061–16065.
Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res, 1995, 55: 2533–2536.
Engelhardt M, Drullinsky P, Guillem J, et al. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res, 1997, 3: 1931–1941.
Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res, 1995, 1: 1245–1251.
Aisner DL, Wright WE, Shay JW. Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev, 2002, 12: 80–85.
Poortinga G, Hannan KM, Snelling H, et al. MAD1 and c-MYC regulate UBF and rDNAtranscription during granulocyte differentiation. EMBO J, 2004, 23: 3325–3335.
Oh S, Song YH, Yim J, et al. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene, 2000, 19: 1445–1490.
Kuhlmann AS, Villaudy J, Gazzolo L, et al. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology, 2007, 4: 92.
Li H, Cao Y, Berndt MC, et al. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene, 1999, 18: 6785–6794.
Bellon M, Nicot C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood, 2008, 112: 2946–2955.
Alonso M, Fueyo J, Shay JW, et al. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst, 2005, 97: 1589–1600.
Zuo QP, Liu SK, Li ZJ, et al. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG2 hepatoma cell line. Eur J Pharmacol, 2011, 672: 113–120.
Tae Ho Lee, Adrian Tun-Kyi, Rong Shi, et al. Essential role of Pin1 in regulation of TRF1 stability and telomere maintenance. Nat Cell Biol, 2009, 11: 97–105.
Xu YX, Manley JL. The prolyl isomerase Pin1 functions in mitotic chromosome condensation. Mol Cell, 2007, 26: 287–300.
Qin LY, Hao H, Li WM, et al. Decreasing Pin1 suppressed the properties of migratory and invasive in colorectal carcinoma SW620 cells. Chinese-German J Clin Oncol, 2010, 4: 216–220.
Zhu Y, Hao H, Li WM, et al. Pin1 expression affects cell proliferation and apoptosis of SW620 cells in colorectal carcinoma. Chinese-German J Clin Oncol, 2011, 2: 100–104.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods, 2001, 25: 402–408.
Ghosh A, Saginc G, Leow SC, et al. Telomerase directly regulates NF-κB-dependent transcription. Nat Cell Biol, 2012, 14: 1270–1281.
Akiyama M, Hideshima T, Hayashi T, et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res, 2002, 62: 3876–3882.
Yin L, Hubbard AK, Giardina C. NF-kappa B regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem, 2000, 24: 36671–36675.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant from the Natural Science Foundation of Shanxi Province (No. 2010011047-1, 2011021035-1)
Rights and permissions
About this article
Cite this article
Sun, J., Fan, L., Li, M. et al. Decreasing Pin1 suppresses telomerase activity by NF-κB in HCT116 cells colorectal carcinoma. Chin. -Ger. J. Clin. Oncol. 12, 181–187 (2013). https://doi.org/10.1007/s10330-013-1137-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-013-1137-7
Key words
- colonic cancer
- Pin1
- hTERT
- NF-κB